Skip to main content
. Author manuscript; available in PMC: 2011 May 6.
Published in final edited form as: J Urol. 2009 Sep 16;182(5):2265–2272. doi: 10.1016/j.juro.2009.07.030

Table 4.

SF-36

Variable Mean ± SE Baseline Score Mean ± SE 6-Wk Score Mean ± SE 12-Wk Score p Value
Physical health summary:
 Placebo 76.25 ± 5.59 74.73 ± 4.38 72.36 ± 5.45 0.869
 Active 64.25 ± 6.17 65.75 ± 6.56 66.92 ± 5.63 0.954
  p Value 0.161 0.272 0.497
Mental health summary:
 Placebo 81.23 ± 4.62 77.37 ± 4.64 80.66 ± 4.87 0.817
 Active 69.67 ± 7.16 71.36 ± 5.62 77.18 ± 4.02 0.642
  p Value 0.186 0.416 0.584
Physical functioning:
 Placebo 83.33 ± 5.53 82.14 ± 4.41 84.23 ± 3.34 0.952
 Active 71.67 ± 6.74 71.33 ± 6.96 78.33 ± 8.07 0.747
  p Value 0.192 0.208 0.528
Physical health role limitation:
 Placebo 80 ± 9.82 71.67 ± 9.41 67.31 ± 12.46 0.69
 Active 63.33 ± 11.67 61.67 ± 11.41 56.67 ± 10.76 0.91
  p Value 0.284 0.504 0.522
Body pain:
 Placebo 78 ± 5.37 74.33 ± 5.93 76.35 ± 5.31 0.893
 Active 66 ± 6.2 73 ± 7.33 74 ± 6.48 0.657
  p Value 0.155 0.889 0.786
General health:
 Placebo 63.67 ± 5.24 65.67 ± 4.57 61.54 ± 5.2 0.848
 Active 56 ± 3.94 57 ± 6.15 58.67 ± 4.77 0.931
  p Value 0.252 0.268 0.687
Energy/fatigue:
 Placebo 64 ± 5.65 63.67 ± 4.1 67.69 ± 4.62 0.819
 Active 50.67 ± 8.24 49.67 ± 7.28 54 ± 5.88 0.906
  p Value 0.193 0.105 0.085
Social functioning:
 Placebo 94.17 ± 4.2 83.33 ± 6.06 89.42 ± 3.7 0.283
 Active 78.33 ± 9 78.33 ± 8.75 88.33 ± 5.38 0.589
  p Value 0.122 0.642 0.873
Emotional problem role limitation:
 Placebo 82.22 ± 9.12 75.56 ± 10.01 76.92 ± 10.93 0.879
 Active 68.89 ± 11.02 75.56 ± 8.27 80 ± 7.83 0.691
  p Value 0.359 1 0.817
Emotional well-being:
 Placebo 84.53 ± 2.7 86.93 ± 2.54 88.62 ± 2.43 0.542
 Active 80.8 ± 3.87 81.87 ± 3.53 79.43 ± 3.7 0.899
  p Value 0.435 0.254 0.052